BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+59.64%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
AUM
$883M
AUM Growth
+$883M
Cap. Flow
-$83.4M
Cap. Flow %
-9.44%
Top 10 Hldgs %
73.41%
Holding
36
New
4
Increased
6
Reduced
5
Closed
10
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SLDB icon
1
Solid Biosciences
SLDB
$427M
$99.1M 11.22% 2,780,000 +2,030,000 +271% +$72.3M
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$96.9M 10.97% 630,000
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$77.2M 8.74% 1,565,560 +193,050 +14% +$9.52M
PTCT icon
4
PTC Therapeutics
PTCT
$3.92B
$64.1M 7.26% 1,900,000 -700,000 -27% -$23.6M
ODT
5
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$62.4M 7.07% 2,826,938
WVE icon
6
Wave Life Sciences
WVE
$1.53B
$60.8M 6.89% 1,590,600 +240,600 +18% +$9.2M
ESPR icon
7
Esperion Therapeutics
ESPR
$448M
$53.9M 6.1% 1,375,000 +475,000 +53% +$18.6M
SRPT icon
8
Sarepta Therapeutics
SRPT
$1.78B
$49.6M 5.61% +375,000 New +$49.6M
MDCO
9
DELISTED
Medicines Co
MDCO
$45.9M 5.19% 1,250,000
RCKT icon
10
Rocket Pharmaceuticals
RCKT
$354M
$38.6M 4.37% 1,966,051
VKTX icon
11
Viking Therapeutics
VKTX
$3.04B
$35.6M 4.03% 3,750,000 +564,000 +18% +$5.35M
CBAY
12
DELISTED
Cymabay Therapeutics
CBAY
$28.1M 3.18% 2,094,000 -618,986 -23% -$8.31M
MDGL icon
13
Madrigal Pharmaceuticals
MDGL
$9.76B
$26.6M 3.01% +95,000 New +$26.6M
MGNX icon
14
MacroGenics
MGNX
$112M
$25.7M 2.91% 1,245,000 -955,000 -43% -$19.7M
DBVT
15
DBV Technologies
DBVT
$264M
$20.5M 2.33% 1,065,000 +45,000 +4% +$868K
KNSA icon
16
Kiniksa Pharmaceuticals
KNSA
$2.48B
$20.3M 2.3% +1,172,700 New +$20.3M
ONCT
17
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$20.1M 2.27% 1,310,000 -280,000 -18% -$4.29M
KURA icon
18
Kura Oncology
KURA
$686M
$15.4M 1.74% 844,789
MEIP icon
19
MEI Pharma
MEIP
$160M
$11.5M 1.3% +2,913,091 New +$11.5M
RETA
20
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$11.4M 1.29% 325,000
RIGL icon
21
Rigel Pharmaceuticals
RIGL
$697M
$6.57M 0.74% 2,321,900 -2,818,100 -55% -$7.98M
VIRX
22
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.51M 0.51% 2,125,000
BLPH
23
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$4.49M 0.51% 1,857,143
ELDN icon
24
Eledon Pharmaceuticals
ELDN
$155M
$2.27M 0.26% 324,383
RGLS
25
DELISTED
Regulus Therapeutics
RGLS
$1.12M 0.13% 1,697,802